<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0167369</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-31783</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Bacterial diseases</subject><subj-group><subject>Staphylococcal infection</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Staphylococcus</subject><subj-group><subject>Staphylococcus aureus</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Staphylococcus</subject><subj-group><subject>Staphylococcus aureus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Staphylococcus</subject><subj-group><subject>Staphylococcus aureus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Clinical trials</subject><subj-group><subject>Randomized controlled trials</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug research and development</subject><subj-group><subject>Clinical trials</subject><subj-group><subject>Randomized controlled trials</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Clinical trials</subject><subj-group><subject>Randomized controlled trials</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Staphylococcus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Staphylococcus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Staphylococcus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Antimicrobials</subject><subj-group><subject>Antibiotics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial control</subject><subj-group><subject>Antimicrobials</subject><subj-group><subject>Antibiotics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Staphylococcus</subject><subj-group><subject>Staphylococcus aureus</subject><subj-group><subject>Methicillin-resistant Staphylococcus aureus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Staphylococcus</subject><subj-group><subject>Staphylococcus aureus</subject><subj-group><subject>Methicillin-resistant Staphylococcus aureus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Staphylococcus</subject><subj-group><subject>Staphylococcus aureus</subject><subj-group><subject>Methicillin-resistant Staphylococcus aureus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Mupirocin in the Treatment of Staphylococcal Infections in Chronic Rhinosinusitis: A Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Effect of Mupirocin on Recalcitrant Staphylococcal Sinusitis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1384-6799</contrib-id>
<name name-style="western">
<surname>Kim</surname>
<given-names>Jong Seung</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Kwon</surname>
<given-names>Sam Hyun</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chonbuk National University, Jeonju, Republic of Korea</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Research Institute of Clinical Medicine of Chonbuk National University–Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Republic of Korea</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Thierry</surname>
<given-names>Benjamin</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of South Australia, AUSTRALIA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item><p><bold>Conceptualization:</bold> SHK.</p></list-item> <list-item><p><bold>Data curation:</bold> SHK.</p></list-item> <list-item><p><bold>Formal analysis:</bold> JSK.</p></list-item> <list-item><p><bold>Funding acquisition:</bold> SHK.</p></list-item> <list-item><p><bold>Investigation:</bold> JSK.</p></list-item> <list-item><p><bold>Methodology:</bold> JSK.</p></list-item> <list-item><p><bold>Project administration:</bold> SHK.</p></list-item> <list-item><p><bold>Resources:</bold> SHK.</p></list-item> <list-item><p><bold>Software:</bold> JSK.</p></list-item> <list-item><p><bold>Supervision:</bold> SHK.</p></list-item> <list-item><p><bold>Validation:</bold> SHK JSK.</p></list-item> <list-item><p><bold>Visualization:</bold> JSK.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> JSK.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> SHK.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">shkwon@jbnu.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>1</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>12</issue>
<elocation-id>e0167369</elocation-id>
<history>
<date date-type="received">
<day>9</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Kim, Kwon</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0167369"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Saline irrigation of the nasal cavity is a classic and effective treatment for acute or chronic rhinosinusitis. Topical antibiotics such as mupirocin have been widely used for recalcitrant chronic rhinosinusitis. Therefore, the purpose of this study was to evaluate the effect of saline irrigation using mupirocin.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>A systematic literature review and meta-analysis of mupirocin saline irrigation were performed using EMBASE, MEDLINE, and Cochrane library through December 2015. Data were analyzed with R 3.2.2 software. A random effects model was used because of the diversity of included studies. Sensitivity analysis of particular tested groups and single proportion tests were also performed. The main outcome measure was residual staphylococcal infection, as confirmed by culture or PCR.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Two RCTs, two prospective studies and two retrospective studies were included. A random effects model meta-analysis of the pooled data identified a relative risk of residual infection of 0.13 (95% CI: 0.06–0.26, p&lt;0.05) with low heterogeneity (I<sup>2</sup> = 0%). The proportion of residual staphylococcal infections after 1 month was 0.08 (95% CI: 0.04–0.16). However, this proportion increased to 0.53 at 6 months (95% CI: 0.27–0.78).</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>The short-term use of mupirocin has a strongly reductive effect on staphylococcal infection in chronic rhinosinusitis. Although there is currently a lack of clear evidence, future studies with well-designed inclusion criteria and randomized controlled trials are needed to examine mupirocin’s long-term effect on chronic rhinosinusitis.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>This paper was supported by a fund of the Biomedical Research Institute at Chonbuk National University Hospital.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="1"/>
<page-count count="11"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>Data are available from Open Science Framework at the following URL: <ext-link ext-link-type="uri" xlink:href="https://osf.io/z8gtd/" xlink:type="simple">https://osf.io/z8gtd/</ext-link>.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Saline irrigation of the nasal cavity is a classic and powerful method to treat acute or chronic rhinosinusitis (CRS) [<xref ref-type="bibr" rid="pone.0167369.ref001">1</xref>]. It can be used in allergic or nonallergic rhinitis, postoperative care of endoscopic sinus surgery or septal surgery, and atrophic rhinitis [<xref ref-type="bibr" rid="pone.0167369.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0167369.ref003">3</xref>]. Nasal irrigation works by mechanically removing inflammatory mucin and therefore enhancing mucociliary function [<xref ref-type="bibr" rid="pone.0167369.ref004">4</xref>]. Bacterial biofilms may develop in refractory CRS, which persist after sinus surgery or culture-based antibiotic therapy [<xref ref-type="bibr" rid="pone.0167369.ref005">5</xref>]. However, classic saline irrigation and oral antibiotics have a limited effect on these refractory cases.</p>
<p>Recently, saline irrigation mixed with a topical agent have been introduced to treat these recalcitrant CRS cases [<xref ref-type="bibr" rid="pone.0167369.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0167369.ref006">6</xref>]. Typical topical agents include topical antifungal agents, steroids, surfactants, xylitol and topical antibiotics [<xref ref-type="bibr" rid="pone.0167369.ref007">7</xref>–<xref ref-type="bibr" rid="pone.0167369.ref011">11</xref>]. Of these agents, mupirocin also has significant anti-staphylococcal activity. It is highly effective against methicillin-susceptible (MSSA) and -resistant <italic>Staphylococcus aureus</italic> (MRSA) strains that colonize the nasal cavities and sinuses [<xref ref-type="bibr" rid="pone.0167369.ref006">6</xref>]. In this study, our purpose was to evaluate the efficacy of saline irrigation with mupirocin to treat recalcitrant CRS using a systematic review and meta-analysis.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec007">
<title>Ethical considerations</title>
<p>This is a systematic retrospective review of previously published articles, and no patient identifiable details are included.</p>
</sec>
<sec id="sec008">
<title>Literature search</title>
<p>Institutional review board approval and patient consent were not required due to the nature of this study. The study was conducted in compliance with the PRISMA check list (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) [<xref ref-type="bibr" rid="pone.0167369.ref012">12</xref>] (<bold><xref ref-type="supplementary-material" rid="pone.0167369.s001">S1 PRISMA Checklist</xref>).</bold> The MEDLINE, EMBASE and Cochrane databases were searched for eligible studies published up to and including December 2015. The research key words included “mupirocin,” “irrigation,” “saline,” “sinus surgery,” and “sinusitis.” The following search formula was used in MEDLINE: ("mupirocin"[MeSH Terms] OR "mupirocin"[All Fields]) AND (("sinusitis"[MeSH Terms] OR "sinusitis"[All Fields]) OR (("paranasal sinuses"[MeSH Terms] OR ("paranasal"[All Fields] AND "sinuses"[All Fields]) OR "paranasal sinuses"[All Fields] OR "sinus"[All Fields]) AND ("surgery"[Subheading] OR "surgery"[All Fields] OR "surgical procedures, operative"[MeSH Terms] OR ("surgical"[All Fields] AND "procedures"[All Fields] AND "operative"[All Fields]) OR "operative surgical procedures"[All Fields] OR "surgery"[All Fields] OR "general surgery"[MeSH Terms] OR ("general"[All Fields] AND "surgery"[All Fields]) OR "general surgery"[All Fields])) OR ("therapeutic irrigation"[MeSH Terms] OR ("therapeutic"[All Fields] AND "irrigation"[All Fields]) OR "therapeutic irrigation"[All Fields] OR "irrigation"[All Fields]))</p>
<p>Similar search words were used in each database.</p>
</sec>
<sec id="sec009">
<title>Selection criteria</title>
<p>Eligible studies met the following inclusion criteria: (1) full-length original article providing dichotomous data to evaluate the effects of mupirocin irrigation on the recurrence of sinusitis; (2) prospective or retrospective cohort study, randomized controlled trial; (3) primary outcomes were expressed with residual staphylococcal colonization which was assessed by culture or polymerase chain reaction (PCR). Studies were excluded if: (1) the treatment modalities contained other topical agents; (2) the article was not written in English; (3) the study had no relation to sinusitis; (4) the study included in vitro studies; (5) the study had duplicate data or incomplete data for calculating the effect sizes; (6) the study was an unpublished trial.</p>
</sec>
<sec id="sec010">
<title>Data extraction</title>
<p>Two authors independently extracted information from all eligible studies. Any disparities were resolved by consensus. Data including the first author’s name and publication date were collected. The Newcastle-Ottawa Scale was used to assess study quality of case–control and cohort studies, and the Cochrane risk of bias tool was employed for randomized controlled trials (RCTs) [<xref ref-type="bibr" rid="pone.0167369.ref013">13</xref>].</p>
</sec>
<sec id="sec011">
<title>Treatment outcomes</title>
<p>The proportion of treatment failure cases in the experimental group was obtained by dividing the number of cases with treatment failure by the total number of cases in the study. The proportion of treatment failure cases in the control group was calculated using the same method. The primary outcome was presented in the event of treatment failure which was defined in our study by residual staphylococcal colonization [<xref ref-type="bibr" rid="pone.0167369.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0167369.ref019">19</xref>].</p>
</sec>
<sec id="sec012">
<title>Statistical analysis</title>
<p>The effect size was represented by the risk ratio of residual staphylococcal infection, which was compared between the mupirocin group and the control group. The standard error was also calculated for each clinical outcome measure. Hedge’s g and standard error were determined for each treatment outcome measure. The 95% confidence interval (CI) was then computed for each type of therapy. The random effects model was used considering the effects from different locations, populations, and heterogenous research groups, which were the main causes of the within-study and between-study variations.</p>
<p>R 3.2.2 software (R Foundation) was used to analyze and graphically display the meta-analysis data. We calculated relative risk with a 95% CI for the treatment outcome. Heterogeneity between studies was assessed using the I<sup>2</sup> statistic. P-values&lt;0.10 and I<sup>2</sup>&gt;50% indicated evidence of heterogeneity [<xref ref-type="bibr" rid="pone.0167369.ref020">20</xref>]. Potential publication bias was investigated using funnel plots. If a publication bias was suspected, Duval’s trim and fill method was used to correct for the bias using R 3.1.2 [<xref ref-type="bibr" rid="pone.0167369.ref021">21</xref>–<xref ref-type="bibr" rid="pone.0167369.ref023">23</xref>]. A sensitivity analysis was carried out to identify any outlier studies.</p>
</sec>
</sec>
<sec id="sec013" sec-type="results">
<title>Results</title>
<sec id="sec014">
<title>Study selection</title>
<p>The literature search identified 215 articles. Only six of these articles met the inclusion criteria after the reviewers’ selection. The PRISMA flow diagram of this systematic review is shown in <xref ref-type="fig" rid="pone.0167369.g001">Fig 1</xref>. (<xref ref-type="supplementary-material" rid="pone.0167369.s002">S1 File</xref>) During the screening process of titles and abstracts, a total of 173 studies were excluded because they did not meet the inclusion criteria. Twelve duplicated records were also excluded. The remaining 30 articles qualified for full-text reading, and these were systematically reviewed. After reviewing the full text, 24 publications were excluded because they failed to meet our eligibility criteria (eight articles did not include mupirocin irrigation, nine had insufficient data, six had abstractive narration, and one was a poster presentation). Therefore, six articles were finally included in our qualitative analysis (<xref ref-type="table" rid="pone.0167369.t001">Table 1</xref>). Of these six studies, three studies had no control group. Therefore, three articles were used for effect comparison.</p>
<fig id="pone.0167369.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167369.g001</object-id>
<label>Fig 1</label>
<caption>
<title>PRISMA guidelines for the study literature search (n = number of studies).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167369.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0167369.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167369.t001</object-id>
<label>Table 1</label> <caption><title>Demographics of included studies</title></caption>
<alternatives>
<graphic id="pone.0167369.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167369.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2">Study</th>
<th align="left" colspan="2">Mupirocin group</th>
<th align="left" colspan="2">Control group</th>
<th align="left" rowspan="2">Concentration of mupirocin</th>
<th align="left" rowspan="2">FU</th>
<th align="left" rowspan="2">Treatment outcome</th>
<th align="left" rowspan="2">Methodology</th>
<th align="left" rowspan="2">Quality Score</th>
</tr>
<tr>
<th align="left">Residual Staphlylococcal cases</th>
<th align="left">Total</th>
<th align="left">Residual Staphlylococcal cases</th>
<th align="left">Total</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="2">Jervis-Bardy et al. (2012) [<xref ref-type="bibr" rid="pone.0167369.ref018">18</xref>]</td>
<td align="left">1</td>
<td align="left">9</td>
<td align="left">13</td>
<td align="left">13</td>
<td align="left" rowspan="2">125 mg mupirocin/ 240 ml saline for 1 month</td>
<td align="left">1 month</td>
<td align="left" rowspan="2"><italic>S</italic>. <italic>aureus</italic> culture, Endoscopy, Sx score</td>
<td align="left" rowspan="2">RCT</td>
<td align="left" rowspan="2">Low risk<xref ref-type="table-fn" rid="t001fn003">†</xref></td>
</tr>
<tr>
<td align="left">1</td>
<td align="left">6</td>
<td align="left"/>
<td align="left"/>
<td align="left">6 months</td>
</tr>
<tr>
<td align="left" rowspan="3">Doebbeling et al. (1994) [<xref ref-type="bibr" rid="pone.0167369.ref019">19</xref>]</td>
<td align="left">4</td>
<td align="left">31</td>
<td align="left">30</td>
<td align="left">32</td>
<td align="left" rowspan="3">2% mupirocin twice daily for 5 days</td>
<td align="left">1 month</td>
<td align="left" rowspan="3"><italic>S</italic>. <italic>aureus</italic> culture</td>
<td align="left" rowspan="3">RCT</td>
<td align="left" rowspan="3">Unclear risk<xref ref-type="table-fn" rid="t001fn003">†</xref></td>
</tr>
<tr>
<td align="left">15</td>
<td align="left">31</td>
<td align="left">23</td>
<td align="left">32</td>
<td align="left">6 months</td>
</tr>
<tr>
<td align="left">16</td>
<td align="left">31</td>
<td align="left">24</td>
<td align="left">32</td>
<td align="left">1 year</td>
</tr>
<tr>
<td align="left">Seiberling et al. (2013) [<xref ref-type="bibr" rid="pone.0167369.ref016">16</xref>]</td>
<td align="left">1</td>
<td align="left">16</td>
<td align="left">15</td>
<td align="left">16</td>
<td align="left">60 mg mupirocin/ 240 ml saline given once only</td>
<td align="left">10 days</td>
<td align="left">PCR of <italic>S</italic>. <italic>aureus</italic></td>
<td align="left">Prospective study</td>
<td align="left">8<xref ref-type="table-fn" rid="t001fn004">*</xref></td>
</tr>
<tr>
<td align="left">Jervis-Bardy and Wormald (2012) [<xref ref-type="bibr" rid="pone.0167369.ref017">17</xref>]</td>
<td align="left">42</td>
<td align="left">57</td>
<td align="left"/>
<td align="left"/>
<td align="left">0.05% mupirocin twice daily for 4 weeks</td>
<td align="left">5 months (mean)</td>
<td align="left"><italic>S</italic>. <italic>aureus</italic> culture</td>
<td align="left">Retrospective chart review</td>
<td align="left">6<xref ref-type="table-fn" rid="t001fn004">*</xref></td>
</tr>
<tr>
<td align="left">Uren et al. (2008) [<xref ref-type="bibr" rid="pone.0167369.ref014">14</xref>]</td>
<td align="left">1</td>
<td align="left">16</td>
<td align="left"/>
<td align="left"/>
<td align="left">0.05%, 100 mg mupirocin/ 200 ml saline twice daily for 3 weeks</td>
<td align="left">3 weeks</td>
<td align="left"><italic>S</italic>. <italic>aureus</italic> culture, Endoscopy, Sx score</td>
<td align="left">Prospective study</td>
<td align="left">6<xref ref-type="table-fn" rid="t001fn004">*</xref></td>
</tr>
<tr>
<td align="left">Solares et al. (2006) [<xref ref-type="bibr" rid="pone.0167369.ref015">15</xref>]</td>
<td align="left">1</td>
<td align="left">42</td>
<td align="left"/>
<td align="left"/>
<td align="left">2% mupirocin 440 mg/ 1 L saline twice daily for 4 weeks</td>
<td align="left">4 weeks</td>
<td align="left"><italic>S</italic>. <italic>aureus</italic> culture</td>
<td align="left">Retrospective chart review</td>
<td align="left">6<xref ref-type="table-fn" rid="t001fn004">*</xref></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Abbreviations: FU, follow-up; RCT, randomized controlled trial; CT, computed tomography; PCR, polymerase chain reaction; Sx, symptom</p></fn>
<fn id="t001fn002"><p>Risk of bias:</p></fn>
<fn id="t001fn003"><p>†Cochrane risk of bias</p></fn>
<fn id="t001fn004"><p>*Newcastle-Ottawa quality assessment scale.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>Meta-analysis</title>
<p>Six studies were included in the overall analysis. Only three of these studies had a control group and these were analyzed by comparative meta-analysis (<xref ref-type="table" rid="pone.0167369.t001">Table 1</xref>) [<xref ref-type="bibr" rid="pone.0167369.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0167369.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0167369.ref019">19</xref>]. A random effects model of the pooled data from these three studies (n = 101 patients) showed a 0.13 relative risk (RR) of residual infection at 1 month after treatment (95% CI: 0.06–0.26, p&lt;0.01) (<xref ref-type="fig" rid="pone.0167369.g002">Fig 2A</xref>) with low heterogeneity (I<sup>2</sup> = 0%). Mupirocin reduced the risk of residual infection by approximately 87% compared to that in the control group. The pooled risk difference was calculated to be -0.85 (95% CI: -0.75–-0.95, p&lt;0.01) (<xref ref-type="fig" rid="pone.0167369.g002">Fig 2B</xref>).</p>
<fig id="pone.0167369.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167369.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Forest plot of the effect of mupirocin on recalcitrant CRS.</title>
<p>(A) The pooled relative risk (RR) of 0.13 was calculated using the inverse variance method and random effects model. (B) The pooled risk difference was calculated to be 0.83.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167369.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec016">
<title>Evaluation of publication bias</title>
<p>In a funnel plot of mupirocin saline irrigations, the studies were distributed in the center of the plot, suggesting minimal publication bias (<xref ref-type="fig" rid="pone.0167369.g003">Fig 3</xref>).</p>
<fig id="pone.0167369.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167369.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Funnel plot showing that the studies were mostly spread around the midline of the pyramid.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167369.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>Sensitivity analysis</title>
<p>A sensitivity analysis was performed to evaluate the stability of the results by removing each study one by one in random order. In the overall comparison, the pooled risk ratio and the stratified analyses were not significantly changed, indicating a stable and robust outcome (<xref ref-type="fig" rid="pone.0167369.g004">Fig 4A</xref>).</p>
<fig id="pone.0167369.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0167369.g004</object-id>
<label>Fig 4</label>
<caption>
<title/>
<p>(A) Sensitivity analysis. The pooled risk ratio in the overall comparison was not significantly changed, indicating a stable outcome. (B) Single proportion analysis at 1 month. The proportion of residual <italic>Staphylococcus aureus</italic> was 0.08 (95% CI: 0.04–0.16). (C) The proportion increased to 0.53 at 6 months (95% CI: 0.27–0.78).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0167369.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec018">
<title>Single proportion analysis</title>
<p>Due to limited data from comparison groups (n = 3), single proportion analysis was conducted at 1 and 6 months after mupirocin treatment through all of the included studies [<xref ref-type="bibr" rid="pone.0167369.ref024">24</xref>–<xref ref-type="bibr" rid="pone.0167369.ref027">27</xref>]. After the first month, the proportion of residual staphylococcal infection was 0.08 (95% CI: 0.04–0.16). The proportion increased to 0.53 at 6 months (95% CI: 0.27–0.78) (<xref ref-type="fig" rid="pone.0167369.g004">Fig 4B and 4C</xref>).</p>
</sec>
</sec>
<sec id="sec019" sec-type="conclusions">
<title>Discussion</title>
<p><italic>Staphylococcus aureus</italic> (<italic>S</italic>. <italic>aureus</italic>) is a common pathogen in chronic rhinosinusitis (CRS) [<xref ref-type="bibr" rid="pone.0167369.ref028">28</xref>]. There are two main theories for the development of recurrent CRS: biofilm formation and superantigen formation. Methicillin-resistant <italic>S</italic>. <italic>aureus</italic> (MRSA) has appeared as a result of β lactamase activity; unfortunately, the prevalence of MRSA is now increasing worldwide [<xref ref-type="bibr" rid="pone.0167369.ref029">29</xref>]. The pathophysiology of biofilm development in CRS includes both bacterial and host factors. The essential organism in a biofilm, which is also associated with poor clinical outcomes, is coagulase-positive <italic>S</italic>. <italic>aureus</italic> [<xref ref-type="bibr" rid="pone.0167369.ref030">30</xref>]. <italic>S</italic>. <italic>aureus</italic> that colonizes within epithelial cells releases enterotoxins and induces a topical multiclonal IgE-formation as well as a steroid-insensitive eosinophilic inflammation [<xref ref-type="bibr" rid="pone.0167369.ref031">31</xref>]. These enterotoxins acts as superantigens. The superantigens induce secretion of interleukin-5, eosinophil cationic protein, and immunoglobulin E, which play a pivotal role in the pathogenesis of CRS with nasal polyps [<xref ref-type="bibr" rid="pone.0167369.ref032">32</xref>,<xref ref-type="bibr" rid="pone.0167369.ref033">33</xref>]. From these mechanisms, therapeutic approaches including antibiotics and anti-interleukin-5 are in the limelight in the nonsurgical treatment of CRS. Topical antibiotics are used clinically for many sites, including the external and middle ears, eyes, oral mucosa, and skin. Topical antibiotics are effective because a high concentration of the drug can be applied locally, with minimal systemic effects. Mupirocin, which is isolated from <italic>Pseudomonas fluorescens</italic>, inhibits bacterial growth [<xref ref-type="bibr" rid="pone.0167369.ref034">34</xref>]. It is unstable in human serum; however, it survives in human nasal secretions, where it retains its anti-staphylococcal activity [<xref ref-type="bibr" rid="pone.0167369.ref035">35</xref>]. Mupirocin is a treatment option for recalcitrant CRS. Although there are reports of mupirocin-resistant <italic>S</italic>. <italic>aureus</italic>, mupirocin is the only effective topical agent against MRSA [<xref ref-type="bibr" rid="pone.0167369.ref036">36</xref>].</p>
<p>Two RCTs and one prospective cohort study were included in our final comparative meta-analysis. All three studies used mupirocin before 1 month and evaluated the effect in the same period [<xref ref-type="bibr" rid="pone.0167369.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0167369.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0167369.ref019">19</xref>]. We found that mupirocin treatment had a risk ratio of 0.13 (95% CI: 0.06–0.26, p&lt;0.05) with low heterogeneity (I<sup>2</sup> = 0%; p = 0.75). Therefore, mupirocin saline irrigation reduced the risk of residual staphylococcal infection in recalcitrant CRS by approximately 87% at 1 month. Differences in interventions, programs or populations across the studies were the basis for a random effects model; however, there was little heterogeneity [<xref ref-type="bibr" rid="pone.0167369.ref037">37</xref>,<xref ref-type="bibr" rid="pone.0167369.ref038">38</xref>]. The sensitivity analysis did not identify any outlier studies 1 month after mupirocin treatment. Although some studies had a low score quality, this finding supports the view that the risk ratio is robust and stable [<xref ref-type="bibr" rid="pone.0167369.ref020">20</xref>]. After 1 month, we were unable to perform comparative analysis due to insufficient data.</p>
<p>We also conducted single proportion tests to complement the small sample size of the studies. Although proportion analysis provides weaker evidence than randomized controlled trials, it can be applied to systematic reviews yielding proportion data and confidence intervals [<xref ref-type="bibr" rid="pone.0167369.ref039">39</xref>]. The studies by Jervis-Bardy, Solares, Uren and colleagues [<xref ref-type="bibr" rid="pone.0167369.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0167369.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0167369.ref017">17</xref>] were added to the existing three studies (<xref ref-type="fig" rid="pone.0167369.g004">Fig 4B and 4C</xref>). A random effects model was used. The proportion of residual staphylococcal infections after 1 month was 0.08 (95% CI: 0.04–0.16). However, this proportion increased to 0.53 at 6 months (95% CI: 0.27–0.78). Doebbeling et al. addressed the long-term effects of mupirocin [<xref ref-type="bibr" rid="pone.0167369.ref019">19</xref>]. This group found that, after 5 days of treatment, mupirocin has a strong effect for 1 month; however, this effect decreases after 6 months and is ineffective at 1 year. Jervis-Bardy et al. also reported that 73.7% of patients subsequently cultured <italic>S</italic>. <italic>aureus</italic> following mupirocin treatment during a mean 5-month follow-up [<xref ref-type="bibr" rid="pone.0167369.ref017">17</xref>]. They postulated that any intracellular or interstitial surviving bacteria may regenerate following subtotal eradication. The increase in residual infections during this interval can also be explained by a recent study reporting that the same staphylococcal strain reappeared rather than colonization by a new strain [<xref ref-type="bibr" rid="pone.0167369.ref040">40</xref>]. Intra-mucosal residence during the culture-negative period is proposed as the probable mechanism.</p>
<p>Traditionally, topical mupirocin has been known for its staphylococcal decolonization effect. Edmundson et al. reported that mupirocin was effective in reducing staphylococcal colonization and it fell from 5.88% to 2.71% on subsequent screening [<xref ref-type="bibr" rid="pone.0167369.ref041">41</xref>]. They reported that all asymptomatic staphylococcal nasal carriers receiving single topical mupirocin were successfully cleared of colonization; however, some required more than one course of treatment. McConeghy et al. reported that topical mupirocin is the standard of care for decolonization of <italic>Staphylococcus</italic>, and it is applied to the anterior nares 2–3 times/day for 5 days [<xref ref-type="bibr" rid="pone.0167369.ref042">42</xref>]. According to their report, since staphylococcal colonization often precedes infection, and infection is associated with significant morbidity and mortality, there is great importance in preventing the transmission of <italic>Staphylococcus</italic> and decolonizing patients who harbor these bacteria. Similarly, we found that topical mupirocin irrigation reduced the risk of residual staphylococcal infection in recalcitrant CRS by approximately 87% at 1 month. <italic>Staphylococcus</italic> that shows antimicrobial resistance is known to be an increasingly important cause of chronic rhinosinusitis [<xref ref-type="bibr" rid="pone.0167369.ref043">43</xref>]. In this regard, mupirocin irrigation has the short-term effect of eradicating residual staphylococcal infection which may aggravate chronic rhinosinusitis.</p>
<p>The content of mupirocin varied across the studies (0.05–2%) [<xref ref-type="bibr" rid="pone.0167369.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0167369.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0167369.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0167369.ref019">19</xref>]. However, the concentration of mupirocin saline was consistent (440–500 mg/L saline) [<xref ref-type="bibr" rid="pone.0167369.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0167369.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0167369.ref018">18</xref>]. Although Seiberling et al. used a low concentration of mupirocin for irrigation, the risk ratio in their study (0.06) was not different from the overall risk ratio (0.13). Only Doebbeling et al. used pure mupirocin ointment, and the others (Jervis-Bardy, Uren, Solares, Seiberling and colleagues) used mupirocin saline washes (rinses) for irrigation. However, our sensitivity analysis showed that omitting Doebbeling’s study did not change the overall risk ratio (RR = 0.10). So the concentration and method of administering mupirocin did not influence its effect on residual staphylococcal infection.</p>
<p>Our study had several limitations. First, our meta-analysis included some studies which had sparse data with regard to long-term follow-up and usage manuals. Further studies that handle these data will enable meta-regression analysis or moderator analysis to be performed. In addition, our study also included a small number of RCTs. It also included observational studies which had low quality scores. Further RCT studies will enrich and substantiate our findings.</p>
</sec>
<sec id="sec020" sec-type="conclusions">
<title>Conclusion</title>
<p>To our knowledge, this is the first meta-analysis to assess the effects of mupirocin saline irrigation on staphylococcal infection in chronic recalcitrant rhinosinusitis. Mupirocin saline irrigation is an effective short-term treatment for recalcitrant staphylococcal CRS. Future studies that address the long-term effects and moderator variables of mupirocin treatment will overcome the present limitations, and contribute additional clinical information.</p>
</sec>
<sec id="sec021">
<title>Supporting Information</title>
<supplementary-material id="pone.0167369.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0167369.s001" xlink:type="simple">
<label>S1 PRISMA Checklist</label>
<caption>
<title>PRISMA 2009 checklist for this study.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0167369.s002" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0167369.s002" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>PRISMA 2009 flow diagram for this study.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0167369.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lanza</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Kennedy</surname> <given-names>DW</given-names></name>. <article-title>Adult rhinosinusitis defined</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>1997</year>; <volume>117</volume>: <fpage>S1</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="pone.0167369.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moore</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Kern</surname> <given-names>EB</given-names></name>. <article-title>Atrophic rhinitis: a review of 242 cases</article-title>. <source>Am J Rhinol</source>. <year>2001</year>; <volume>15</volume>: <fpage>355</fpage>–<lpage>361</lpage>. <object-id pub-id-type="pmid">11777241</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barham</surname> <given-names>HP</given-names></name>, <name name-style="western"><surname>Harvey</surname> <given-names>RJ</given-names></name>. <article-title>Nasal saline irrigation: therapeutic or homeopathic</article-title>. <source>Braz J Otorhinolaryngol</source>. <year>2015</year>; <volume>81</volume>: <fpage>457</fpage>–<lpage>458</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bjorl.2015.07.002" xlink:type="simple">10.1016/j.bjorl.2015.07.002</ext-link></comment> <object-id pub-id-type="pmid">26324202</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brown</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Graham</surname> <given-names>SM</given-names></name>. <article-title>Nasal irrigations: good or bad?</article-title> <source>Curr Opin Otolaryngol Head Neck Surg</source>. <year>2004</year>; <volume>12</volume>: <fpage>9</fpage>–<lpage>13</lpage>. <object-id pub-id-type="pmid">14712112</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ezzat</surname> <given-names>WF</given-names></name>, <name name-style="western"><surname>Fawaz</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Rabie</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hamdy</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Shokry</surname> <given-names>YA</given-names></name>. <article-title>Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis</article-title>. <source>Eur Arch Otorhinolaryngol</source>. <year>2015</year>; <volume>272</volume>: <fpage>2355</fpage>–<lpage>2361</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00405-014-3301-2" xlink:type="simple">10.1007/s00405-014-3301-2</ext-link></comment> <object-id pub-id-type="pmid">25351496</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grossman</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Nanda</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Dubina</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rademaker</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>West</surname> <given-names>DP</given-names></name>, <etal>et al</etal>. <article-title>Clearance of nasal Staphylococcus aureus colonization with triple antibiotic ointment</article-title>. <source>J Drugs Dermatol</source>. <year>2012</year>; <volume>11</volume>: <fpage>1490</fpage>–<lpage>1492</lpage>. <object-id pub-id-type="pmid">23377521</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rotenberg</surname> <given-names>BW</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Arra</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Payton</surname> <given-names>KB</given-names></name>. <article-title>Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial</article-title>. <source>Laryngoscope</source>. <year>2011</year>; <volume>121</volume>: <fpage>2702</fpage>–<lpage>2705</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/lary.22396" xlink:type="simple">10.1002/lary.22396</ext-link></comment> <object-id pub-id-type="pmid">21997904</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brown</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Graham</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Cable</surname> <given-names>BB</given-names></name>, <name name-style="western"><surname>Ozer</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Taft</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Zabner</surname> <given-names>J</given-names></name>. <article-title>Xylitol enhances bacterial killing in the rabbit maxillary sinus</article-title>. <source>Laryngoscope</source>. <year>2004</year>; <volume>114</volume>: <fpage>2021</fpage>–<lpage>2024</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/01.mlg.0000147939.90249.47" xlink:type="simple">10.1097/01.mlg.0000147939.90249.47</ext-link></comment> <object-id pub-id-type="pmid">15510034</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zabner</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Seiler</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Launspach</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Karp</surname> <given-names>PH</given-names></name>, <name name-style="western"><surname>Kearney</surname> <given-names>WR</given-names></name>, <name name-style="western"><surname>Look</surname> <given-names>DC</given-names></name>, <etal>et al</etal>. <article-title>The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2000</year>; <volume>97</volume>: <fpage>11614</fpage>–<lpage>11619</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.97.21.11614" xlink:type="simple">10.1073/pnas.97.21.11614</ext-link></comment> <object-id pub-id-type="pmid">11027360</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rohrer</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Dion</surname> <given-names>GR</given-names></name>, <name name-style="western"><surname>Brenner</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Abadie</surname> <given-names>WM</given-names></name>, <name name-style="western"><surname>McMains</surname> <given-names>KC</given-names></name>, <name name-style="western"><surname>Thomas</surname> <given-names>RF</given-names></name>, <etal>et al</etal>. <article-title>Surfactant improves irrigant penetration into unoperated sinuses</article-title>. <source>Am J Rhinol Allergy</source>. <year>2012</year>; <volume>26</volume>: <fpage>197</fpage>–<lpage>200</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2500/ajra.2012.26.3761" xlink:type="simple">10.2500/ajra.2012.26.3761</ext-link></comment> <object-id pub-id-type="pmid">22643945</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khalil</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tharwat</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Abdou</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Essa</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Elsawy</surname> <given-names>AH</given-names></name>, <name name-style="western"><surname>Elnakib</surname> <given-names>O</given-names></name>, <etal>et al</etal>. <article-title>The role of antifungal therapy in the prevention of recurrent allergic fungal rhinosinusitis after functional endoscopic sinus surgery: a randomized, controlled study</article-title>. <source>Ear Nose Throat J</source>. <year>2011</year>; <volume>90</volume>: <fpage>E1</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="pone.0167369.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mulrow</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gøtzsche</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Ioannidis</surname> <given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration</article-title>. <source>Ann Intern Med</source>. <year>2009</year>; <volume>151</volume>: <fpage>W65</fpage>–<lpage>94</lpage>. <object-id pub-id-type="pmid">19622512</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stang</surname> <given-names>A</given-names></name>. <article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</article-title>. <source>Eur J Epidemiol</source>. <year>2010</year>; <volume>25</volume>: <fpage>603</fpage>–<lpage>605</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10654-010-9491-z" xlink:type="simple">10.1007/s10654-010-9491-z</ext-link></comment> <object-id pub-id-type="pmid">20652370</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Uren</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Psaltis</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wormald</surname> <given-names>PJ</given-names></name>. <article-title>Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis</article-title>. <source>Laryngoscope</source>. <year>2008</year>; <volume>118</volume>: <fpage>1677</fpage>–<lpage>1680</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MLG.0b013e31817aec47" xlink:type="simple">10.1097/MLG.0b013e31817aec47</ext-link></comment> <object-id pub-id-type="pmid">18545212</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Solares</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Batra</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Hall</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Citardi</surname> <given-names>MJ</given-names></name>. <article-title>Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations</article-title>. <source>Am J Otolaryngol</source>. <year>2006</year>; <volume>27</volume>: <fpage>161</fpage>–<lpage>165</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.amjoto.2005.09.006" xlink:type="simple">10.1016/j.amjoto.2005.09.006</ext-link></comment> <object-id pub-id-type="pmid">16647979</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Seiberling</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Aruni</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Scapa</surname> <given-names>VI</given-names></name>, <name name-style="western"><surname>Fletcher</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Church</surname> <given-names>CA</given-names></name>. <article-title>The effect of intraoperative mupirocin irrigation on Staphylococcus aureus within the maxillary sinus</article-title>. <source>Int Forum Allergy Rhinol</source>. <year>2013</year>; <volume>3</volume>: <fpage>94</fpage>–<lpage>98</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/alr.21076" xlink:type="simple">10.1002/alr.21076</ext-link></comment> <object-id pub-id-type="pmid">23192968</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jervis-Bardy</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wormald</surname> <given-names>PJ</given-names></name>. <article-title>Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery</article-title>. <source>Int Forum Allergy Rhinol</source>. <year>2012</year>; <volume>2</volume>: <fpage>111</fpage>–<lpage>115</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/alr.20106" xlink:type="simple">10.1002/alr.20106</ext-link></comment> <object-id pub-id-type="pmid">22170745</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jervis-Bardy</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Boase</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Psaltis</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Foreman</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wormald</surname> <given-names>PJ</given-names></name>. <article-title>A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis</article-title>. <source>Laryngoscope</source>. <year>2012</year>; <volume>122</volume>: <fpage>2148</fpage>–<lpage>2153</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/lary.23486" xlink:type="simple">10.1002/lary.23486</ext-link></comment> <object-id pub-id-type="pmid">22865576</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doebbeling</surname> <given-names>BN</given-names></name>, <name name-style="western"><surname>Reagan</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Pfaller</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Houston</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Hollis</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Wenzel</surname> <given-names>RP</given-names></name>. <article-title>Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage</article-title>. <source>Arch Intern Med</source>. <year>1994</year>; <volume>154</volume>: <fpage>1505</fpage>–<lpage>1508</lpage>. <object-id pub-id-type="pmid">8018006</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source>. <year>2002</year>; <volume>21</volume>: <fpage>1539</fpage>–<lpage>1558</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/sim.1186" xlink:type="simple">10.1002/sim.1186</ext-link></comment> <object-id pub-id-type="pmid">12111919</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duval</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tweedie</surname> <given-names>R</given-names></name>. <article-title>Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis</article-title>. <source>Biometrics</source>. <year>2000</year>; <volume>56</volume>: <fpage>455</fpage>–<lpage>463</lpage>. <object-id pub-id-type="pmid">10877304</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sutton</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Duval</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Tweedie</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Abrams</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>DR</given-names></name>. <article-title>Empirical assessment of effect of publication bias on meta-analyses</article-title>. <source>BMJ</source>. <year>2000</year>; <volume>320</volume>: <fpage>1574</fpage>–<lpage>1577</lpage>. <object-id pub-id-type="pmid">10845965</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source>. <year>1994</year>; <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name>. <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source>. <year>1986</year>; <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>. <object-id pub-id-type="pmid">3802833</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Agresti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Min</surname> <given-names>Y</given-names></name>. <article-title>Simple improved confidence intervals for comparing matched proportions</article-title>. <source>Stat Med</source>. <year>2005</year>; <volume>24</volume>: <fpage>729</fpage>–<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/sim.1781" xlink:type="simple">10.1002/sim.1781</ext-link></comment> <object-id pub-id-type="pmid">15696504</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Newcombe</surname> <given-names>RG</given-names></name>. <article-title>Two-sided confidence intervals for the single proportion: comparison of seven methods</article-title>. <source>Stat Med</source>. <year>1998</year>; <volume>17</volume>: <fpage>857</fpage>–<lpage>72</lpage>. <object-id pub-id-type="pmid">9595616</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knapp</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hartung</surname> <given-names>J</given-names></name>. <article-title>Improved tests for a random effects meta-regression with a single covariate</article-title>. <source>Stat Med</source>. <year>2003</year>; <volume>22</volume>: <fpage>2693</fpage>–<lpage>710</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/sim.1482" xlink:type="simple">10.1002/sim.1482</ext-link></comment> <object-id pub-id-type="pmid">12939780</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Al-Mutairi</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kilty</surname> <given-names>SJ</given-names></name>. <article-title>Bacterial biofilms and the pathophysiology of chronic rhinosinusitis</article-title>. <source>Curr Opin Allergy Clin Immunol</source>. <year>2011</year>; <volume>11</volume>: <fpage>18</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/ACI.0b013e3283423376" xlink:type="simple">10.1097/ACI.0b013e3283423376</ext-link></comment> <object-id pub-id-type="pmid">21150431</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nikfar</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Shamsizadeh</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ziaei Kajbaf</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kamali Panah</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Khaghani</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Moghddam</surname> <given-names>M</given-names></name>. <article-title>Frequency of methicillin-resistant Staphylococcus aureus nasal carriage in healthy children</article-title>. <source>Iran J Microbiol</source>. <year>2015</year>; <volume>7</volume>: <fpage>67</fpage>–<lpage>71</lpage>. <object-id pub-id-type="pmid">26622966</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Psaltis</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Weitzel</surname> <given-names>EK</given-names></name>, <name name-style="western"><surname>Ha</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Wormald</surname> <given-names>PJ</given-names></name>. <article-title>The effect of bacterial biofilms on post-sinus surgical outcomes</article-title>. <source>Am J Rhinol</source>. <year>2008</year>; <volume>22</volume>: <fpage>1</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2500/ajr.2008.22.3119" xlink:type="simple">10.2500/ajr.2008.22.3119</ext-link></comment> <object-id pub-id-type="pmid">18284851</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Gevaert</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>van Zele</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Perez-Novo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Patou</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Holtappels</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis</article-title>. <source>Rhinology</source>. <year>2005</year> <month>Sep</month>;<volume>43</volume>(<issue>3</issue>): <fpage>162</fpage>–<lpage>168</lpage>. <object-id pub-id-type="pmid">16218508</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bachert</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Patou</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>van Zele</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Gevaert</surname> <given-names>P</given-names></name>. <article-title>Role of staphylococcal superantigens in upper airway disease</article-title>. <source>Curr Opin Allergy Clin Immunol</source>. <year>2008</year>; <volume>8</volume>: <fpage>34</fpage>–<lpage>38</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/ACI.0b013e3282f4178f" xlink:type="simple">10.1097/ACI.0b013e3282f4178f</ext-link></comment> <object-id pub-id-type="pmid">18188015</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Conley</surname> <given-names>DB</given-names></name>, <name name-style="western"><surname>Tripathi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Seiberling</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Suh</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Harris</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Paniagua</surname> <given-names>MC</given-names></name>, <etal>et al</etal>. <article-title>Superantigens and chronic rhinosinusitis II: analysis of T-cell receptor V beta domains in nasal polyps</article-title>. <source>Am J Rhinol</source>. <year>2006</year>; <volume>20</volume>: <fpage>451</fpage>–<lpage>455</lpage>. <object-id pub-id-type="pmid">16955778</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matthijs</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Vander Wauven</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Cornu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Cornelis</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Thomas</surname> <given-names>CM</given-names></name>, <etal>et al</etal>. <article-title>Antimicrobial properties of Pseudomonas strains producing the antibiotic mupirocin</article-title>. <source>Res Microbiol</source>. <year>2014</year>; <volume>165</volume>: <fpage>695</fpage>–<lpage>704</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.resmic.2014.09.009" xlink:type="simple">10.1016/j.resmic.2014.09.009</ext-link></comment> <object-id pub-id-type="pmid">25303834</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sutherland</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Boon</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Griffin</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Masters</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Slocombe</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>AR</given-names></name>. <article-title>Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use</article-title>. <source>Antimicrob Agents Chemother</source>. <year>1985</year>; <volume>27</volume>: <fpage>495</fpage>–<lpage>498</lpage>. <object-id pub-id-type="pmid">3923922</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>K</given-names></name>. <article-title>In vitro antimicrobial activities of fusidic acid and retapamulin against mupirocin- and methicillin-resistant Staphylococcus aureus</article-title>. <source>Ann Dermatol</source>. <year>2015</year>; <volume>27</volume>: <fpage>551</fpage>–<lpage>556</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5021/ad.2015.27.5.551" xlink:type="simple">10.5021/ad.2015.27.5.551</ext-link></comment> <object-id pub-id-type="pmid">26512169</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Riley</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>. <article-title>Interpretation of random effects meta-analyses</article-title>. <source>BMJ</source>. <year>2011</year>; <volume>342</volume>: <fpage>d549</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.d549" xlink:type="simple">10.1136/bmj.d549</ext-link></comment> <object-id pub-id-type="pmid">21310794</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref038"><label>38</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Borenstein</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hedges</surname> <given-names>LV</given-names></name>, <name name-style="western"><surname>Higgins</surname> <given-names>JPT</given-names></name>, <name name-style="western"><surname>Rothstein</surname> <given-names>HR</given-names></name>. <source>Introduction to meta-analysis</source>. <publisher-name>Wiley &amp; Sons Ltd</publisher-name>; <year>2009</year>, p. <fpage>84</fpage>.</mixed-citation></ref>
<ref id="pone.0167369.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xie</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>XS</given-names></name>, <name name-style="western"><surname>Shan</surname> <given-names>XF</given-names></name>, <name name-style="western"><surname>Cai</surname> <given-names>ZG</given-names></name>. <article-title>Efficacy and safety of botulinum toxin type A for treatment of Frey’s syndrome: evidence from 22 published articles</article-title>. <source>Cancer Med</source>. <year>2015</year>; <volume>4</volume>: <fpage>1639</fpage>–<lpage>1650</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/cam4.504" xlink:type="simple">10.1002/cam4.504</ext-link></comment> <object-id pub-id-type="pmid">26310612</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ou</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Drilling</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Singhal</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>NC</given-names></name>, <name name-style="western"><surname>Wallis-Hill</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Wormald</surname> <given-names>PJ</given-names></name>, <etal>et al</etal>. <article-title>Association of intracellular Staphylococcus aureus with prognosis in chronic rhinosinusitis</article-title>. <source>Int Forum Allergy Rhinol</source>. <year>2016</year> <month>Aug</month>; <volume>6</volume>(<issue>8</issue>): <fpage>792</fpage>–<lpage>799</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/alr.21758" xlink:type="simple">10.1002/alr.21758</ext-link></comment> <object-id pub-id-type="pmid">27080195</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Edmundson</surname> <given-names>SP</given-names></name>, <name name-style="western"><surname>Hirpara</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Bennett</surname> <given-names>D</given-names></name>. <article-title>The effectiveness of methicillin-resistant Staphylococcus aureus colonisation screening in asymptomatic healthcare workers in an Irish orthopaedic unit</article-title>. <source>Eur J Clin Microbiol Infect Dis</source>. <year>2011</year> <month>Sep</month>; <volume>30</volume>(<issue>9</issue>): <fpage>1063</fpage>–<lpage>1066</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10096-011-1192-3" xlink:type="simple">10.1007/s10096-011-1192-3</ext-link></comment> <object-id pub-id-type="pmid">21311935</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McConeghy</surname> <given-names>KW</given-names></name>, <name name-style="western"><surname>Mikolich</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>LaPlante</surname> <given-names>KL</given-names></name>. <article-title>Agents for the decolonization of methicillin-resistant Staphylococcus aureus</article-title>. <source>Pharmacotherapy</source>. <year>2009</year> <month>Mar</month>; <volume>29</volume>(<issue>3</issue>): <fpage>263</fpage>–<lpage>280</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1592/phco.29.3.263" xlink:type="simple">10.1592/phco.29.3.263</ext-link></comment> <object-id pub-id-type="pmid">19249946</object-id></mixed-citation></ref>
<ref id="pone.0167369.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rezai</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Pourmousa</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Dadashzadeh</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ahangarkani</surname> <given-names>F</given-names></name>. <article-title>Multidrug resistance pattern of bacterial agents isolated from patient with chronic sinusitis</article-title>. <source>Caspian J Intern Med</source>. <year>2016</year>; <volume>7</volume>(<issue>2</issue>): <fpage>114</fpage>–<lpage>119</lpage>. <object-id pub-id-type="pmid">27386063</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>